Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan Abstract  similar documents
A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova
"... An expansion of the age range of multiple sclerosis (MS) manifestation has been reported recently ..."
 
Vol 13, No 1 (2021) New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis Abstract  similar documents
D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva
"... The process of neurodegeneration in multiple sclerosis (MS) remains an urgent problem of modern ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis Abstract  similar documents
E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva
"... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..."
 
Vol 11, No 4 (2019) Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis Abstract  similar documents
A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova
"... More than 10 multiple sclerosis-modifying drugs (MSMDs) are widely used now. Novel MSMDs should ..."
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Rehabilitation of patients with progressive forms of multiple sclerosis Abstract  similar documents
S. A. Sivertseva, K. S. Anfilofyeva, A. V. Zotova, A. A. Belkin, M. A. Sherman
"... Rehabilitation has an important place in the treatment and management of patients with multiple ..."
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia Abstract  similar documents
A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya
"... Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative ..."
 
Vol 10, No 4 (2018) Environmental factors and a risk for multiple sclerosis in the Altai Territory Abstract  similar documents
I. P. Saldan, I. V. Smagina, S. A. Elchaninova
"... Multiple sclerosis (MS) is a chronic dysimmune neurodegenerative disease of the central nervous ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз The central vein sign in the differential diagnosis of multiple sclerosis Abstract  similar documents
S. E. Belov, A. N. Boyko
"... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..."
 
Vol 11, No 4 (2019) New possibilities for the therapy of secondary progressive multiple sclerosis Abstract  similar documents
A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov
"... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..."
 
Vol 8, No 3 (2016) Epidemiology of multiple sclerosis in the Bryansk Region Abstract  similar documents
Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina
"... Objective: to study the clinical and epidemiological features of multiple sclerosis (MS ..."
 
Vol 9, No 1 (2017) Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region Abstract  similar documents
V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev
"... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..."
 
Vol 4, No 2 (2012) Clinical characteristics of multiple sclerosis in the Tomsk region Abstract  similar documents
V M Alifirova, M A Titova
"... Two hundred and eighty patients (102 men and 178 women; mean age 38.8ё0.7 years) with multiple ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents Abstract  similar documents
M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova
"... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..."
 
Vol 11, No 3 (2019) Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis Abstract  similar documents
A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
"... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..."
 
Vol 13, No 6 (2021) Changes in retinal structures as markers of multiple sclerosis progression Abstract  similar documents
M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak
"... The involvement of the visual pathway in multiple sclerosis (MS) pathology determines ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice Abstract  similar documents
S. V. Petrov, O. V. Boyko, A. N. Boyko
"... give their own experience of its use in the Moscow Multiple Sclerosis Center. Objective: to assess ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Informative value of neuropsychological tests for multiple sclerosis Abstract  similar documents
A. R. Kabaeva, A. N. Boyko
"... Cognitive impairment (CI) occurs in 43–70% of patients with multiple sclerosis (MS) at both early ..."
 
Vol 11, No 3 (2019) Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up Abstract  similar documents
D. S. Kasatkin, S. S. Molchanova, N. N. Spirin
"... Owing to the advent of current methods for the prevention of exacerbations of multiple sclerosis ..."
 
Vol 8, No 3 (2016) Cardiointervalography in patients with multiple sclerosis Abstract  similar documents
A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov
"... Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple ..."
 
Vol 8, No 2 (2016) Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies Abstract  similar documents
N. Yu. Lashch, A. N. Boiko
"... Multiple sclerosis (MS) is a demyelinating disease of the CNS, which affects mainly young able ..."
 
Vol 7, No 1 (2015) Time course of changes in the development of gait disorders in multiple sclerosis Abstract  similar documents
A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova
"... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..."
 
Vol 6, No 3 (2014) Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis Abstract  similar documents
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova
"... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome Abstract  similar documents
A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii
"... According to numerous studies, gut microbiota plays a significant role in multiple sclerosis (MS ..."
 
Vol 12, No 5 (2020) Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets Abstract  similar documents
N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
"... The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly ..."
 
Vol 12, No 3 (2020) Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis Abstract  similar documents
K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
"... Currently, special attention is paid to timely treatment for active forms of multiple sclerosis ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Polymorphic variants in the PVT1 locus affect multiple sclerosis severity Abstract  PDF (Eng)  similar documents
I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova
"... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis Abstract  similar documents
Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko
"... Management of patients with secondary progressive multiple sclerosis (SPMS) remains one ..."
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) Abstract  similar documents
A. N. Boyko
"... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..."
 
Vol 12, No 3 (2020) Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism Abstract  PDF (Eng)  similar documents
I. V. Smagina, K. V. Lunev, S. A. Elchaninova
"... on the relationship of multiple sclerosis (MS) to vitamin D supplementation Objective: to assess the relationship ..."
 
Vol 13, No 2 (2021) COVID-19 vaccination guidelines for patients with multiple sclerosis Abstract  similar documents
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
"... with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Rehabilitation of patients with multiple sclerosis in terms of evidence-based medicine: techniques for digitizing the results Abstract  similar documents
S. A. Ryabov, A. N. Boyko
"... the effectiveness of rehabilitation in patients with multiple sclerosis (MS). It is necessary to investigate ..."
 
Vol 12, No 1 (2020) Association of BAFF gene polymorphisms with multiple sclerosis progression Abstract  PDF (Eng)  similar documents
I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko
"... in the pathogenesis of multiple sclerosis (MS). Objective: to analyze the association of BAFF gene polymorphisms (rs ..."
 
Vol 11, No 1 (2019) Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis Abstract  PDF (Eng)  similar documents
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko
"... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..."
 
Vol 11, No 4 (2019) Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» Abstract  similar documents
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
"... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..."
 
Vol 11, No 3 (2019) Mitochondrial genome and risk of multiple sclerosis Abstract  similar documents
A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova
"... risk of multiple sclerosis (MS). Objective: to analyze the frequency of mtDNA variants in patients ..."
 
Vol 8, No 1 (2016) Multiple sclerosis-related fatigue and possibilities of its correction Abstract  similar documents
N. Yu. Lashch, A. N. Boiko
"... Multiple sclerosis (MS)-related fatigue is encountered in 75–92% of patients and it is one ..."
 
Vol 10, No 1 (2018) New drugs for anti-B-cell therapy of multiple sclerosis Abstract  similar documents
A. N. Boyko, N. Yu. Lashch, M. E. Guseva
"... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..."
 
Vol 8, No 4 (2016) USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev
"... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..."
 
Vol 7, No 1S (2015): Special issue "Epilepsy" Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy Abstract  similar documents
Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov
"... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..."
 
Vol 6, No 2 (2014) Predementia states and dementia in young people Abstract  similar documents
A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova
"... in patients with neuroAIDS, Huntington’s disease, or multiple sclerosis. ..."
 
Vol 3, No 2 (2011) Psychological features of patients with central pain syndrome in multiple sclerosis Abstract  similar documents
M. V. Churyukanov, V. V. Alekseev, M. L. Kukushkin, N. N. Yakhno
"... ) in multiple sclerosis (MS). There was a variety of the clinical manifestations of CPS. An association of pain ..."
 
Vol 7, No 1 (2015) Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use Abstract  similar documents
I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova
"... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..."
 
Vol 14, No 1 (2022) Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice Abstract  similar documents
S. V. Petrov, O. V. Boyko, A. N. Boyko
"... reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice. Patients and methods. 34 ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Mechanisms of brain protection against autoimmune inflammation Abstract  similar documents
A. I. Volkov, M. V. Melnikov, A. N. Boyko
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Analytical epidemiology of multiple sclerosis in the Republic of Kabardino-Balkaria Abstract  similar documents
L. B. Tlapshokova, A. R. Zikhova
"... Multiple sclerosis (MS) is a common autoimmune disease, which etiology includes a complex ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection Abstract  similar documents
M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova
"... for multiple sclerosis (MS) in the presence of persistent herpesvirus infection (PHVI) remain poorly understood ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Genome-wide polygenic analysis of multiple sclerosis markers Abstract  similar documents
Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova
"... Objective: to perform a genome-wide polygenic analysis of multiple sclerosis (MS) markers ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Art therapy possibilities in the complex treatment of patients with multiple sclerosis Abstract  similar documents
M. E. Guseva, O. V. Matvievskaya, A. N. Boyko
"... -progressive multiple sclerosis (MS). Patients and methods. A group of 42 patients (5 men and 37 women, mean ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study Abstract  similar documents
Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko
"... The problem of an adequate choice of a treatment method in multiple sclerosis (MS) remains one ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis Abstract  similar documents
I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko
"... to the development/progression of many diseases, including cerebrovascular disease and multiple sclerosis. Von ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic Abstract  similar documents
E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov
"... institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss ..."
 
Vol 8, No 4 (2016) GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS Abstract  similar documents
T. E. Shmidt
"... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..."
 
Vol 10, No 3 (2018) Balo's concentric sclerosis: a clinical case Abstract  PDF (Eng)  similar documents
I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin
"... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis Abstract  PDF (Eng)  similar documents
M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova
"... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..."
 
Vol 10, No 2 (2018) CLIPPERS syndrome Abstract  similar documents
T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno
 
Vol 7, No 3 (2015) Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev
"... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..."
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Reduced expression of the tumor necrosis factor gene in blood mononuclear cells in radiologically isolated syndrome – validation of transcriptome analysis results Abstract  similar documents
M. S. Kozin, N. M. Baulina, I. S. Kiselev, A. R. Kabaeva, A. N. Boyko, O. O. Favorova, O. G. Kulakova
"... (MRI) reveals lesions of the white matter of the brain and/or spinal cord characteristic of multiple ..."
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) Abstract  similar documents
M. A. Omarova, M. S. Kozin, A. N. Boyko
"... in the concentration of miRNAs in the CSF of patients with multiple sclerosis (MS) and patients with other neurological ..."
 
Vol 13, No 3 (2021) Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody Abstract  similar documents
A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
"... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..."
 
Vol 14, No 2 (2022) Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity Abstract  similar documents
N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova
"... The role of miRNAs – small, regulatory, noncoding RNAs – in the multiple sclerosis (MS ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Acute inflammatory demyelinating pseudotumor after COVID-19 Abstract  similar documents
T. I. Yakushina, D. M. Yakushin, I. O. Shtang
"... . Such a focus can be a sign of multiple sclerosis onset, be a symptom of acute disseminated encephalomyelitis ..."
 
Vol 12, No 3 (2020) Anti-MOG associated myelitis Abstract  PDF (Eng)  similar documents
A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko
"... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..."
 
Vol 8, No 2 (2016) Histological classification of mesial temporal sclerosis Abstract  similar documents
D. V. Dmitrenko, M. A. Stroganova, N. A. Shnaider, G. P. Martynova, K. A. Gazenkampf, A. V. Dyuzhakova, Yu. S. Panina
"... Mesial temporal sclerosis (MTS) is the most common histopathology occurring in patients with drug ..."
 
Vol 8, No 3 (2016) Amyotrophic lateral sclerosis with extension of the central canal of the spinal cord according to magnetic resonance imaging data Abstract  similar documents
E. G. Mendelevich, G. R. Mukhamedzhanova, E. I. Bogdanov
"... The paper describes an atypical case of amyotrophic lateral sclerosis (ALS) concurrent ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ Magnetic resonance spectroscopy of the brain in the diagnosis of temporal lobe epilepsy Abstract  similar documents
E. S. Solomatova, N. A. Shnaider, A. A. Molgachev, D. V. Dmitrenko, I. G. Strotskaya
 
Vol 9, No 3 (2017) The severity of respiratory disorders in different forms of amyotrophic lateral sclerosis Abstract  similar documents
Yu. N. Rushkevich, N. M. Chechik, S. A. Likhachev, O. V. Merkul, T. V. Korbut
"... with amyotrophic lateral sclerosis (ALS) and promote the addition of serious respiratory and cardiovascular ..."
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... The concurrence of amyotrophic lateral sclerosis (ALS) with parkinsonism syndrome and dementia ..."
 
Vol 14, No 1 (2022) COVID 19 in a family with rare genetic disease of the nervous system Abstract  PDF (Eng)  similar documents
M. Yu. Martynov, V. A. Kutashov, O. V. Ulyanova
"... We present familial tuberous sclerosis (TS) case complicated by COVID-19. COVID-19 aggravates ..."
 
Vol 7, No 2 (2015) Psychopathological manifestations of multiple meningiomas in the right hemisphere Abstract  similar documents
A. A. Lukshina, O. S. Zaitsev, I. A. Nagorskaya, D. Yu. Usachev, V. A. Lukshin
"... with these tumors. The authors provide a clinical and psychopathological analysis of a female patient with multiple ..."
 
Vol 14, No 1 (2022) COVID-19 associated multiple cranial neuropathies Abstract  similar documents
M. Yu. Maksimova, Ya. O. Grusha, E. I. Fettser
"... an early manifestation of SARS-CoV2 infection. Similar to the involvement of the olfactory bulb, multiple ..."
 
1 - 70 of 72 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)